Literature DB >> 17340211

Vascular permeability in ocular disease and the role of tight junctions.

Kathryn K Erickson1, Jeffrey M Sundstrom, David A Antonetti.   

Abstract

Vascular permeability is closely linked with angiogenesis in a number of pathologies. In the retina, the normally well-developed blood-retinal barrier is altered in a host of eye diseases preceding or commensurate with angiogenesis. This review examines the literature regarding the tight junction complex that establishes the blood-retinal barrier focusing on the transmembrane proteins occludin and the claudin family and the membrane associated protein zonula occludens. The changes observed in these proteins associated with vascular and epithelial permeability is discussed. Finally, novel literature addressing the link between the tight junction complex and angiogenesis is considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340211     DOI: 10.1007/s10456-007-9067-z

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  72 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

2.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 3.  The blood-brain barrier.

Authors:  Felix Dyrna; Sophie Hanske; Martin Krueger; Ingo Bechmann
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-06       Impact factor: 4.147

4.  A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.

Authors:  David G Callanan; Anat Loewenstein; Sunil S Patel; Pascale Massin; Borja Corcóstegui; Xiao-Yan Li; Jenny Jiao; Yehia Hashad; Scott M Whitcup
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-08       Impact factor: 3.117

5.  Oxidative stress-induced disruption of epithelial and endothelial tight junctions.

Authors:  Radhakrishna Rao
Journal:  Front Biosci       Date:  2008-05-01

6.  Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein.

Authors:  Xi-Yu Mei; Ling-Yu Zhou; Tian-Yu Zhang; Bin Lu; Li-Li Ji
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

7.  IQGAP1 controls tight junction formation through differential regulation of claudin recruitment.

Authors:  Barbara E Tanos; Andres E Perez Bay; Susana Salvarezza; Igor Vivanco; Ingo Mellinghoff; Mahasin Osman; David B Sacks; Enrique Rodriguez-Boulan
Journal:  J Cell Sci       Date:  2015-01-14       Impact factor: 5.285

8.  Deletion of hemojuvelin, an iron-regulatory protein, in mice results in abnormal angiogenesis and vasculogenesis in retina along with reactive gliosis.

Authors:  Amany Tawfik; Jaya P Gnana-Prakasam; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

9.  Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.

Authors:  Michael I Dorrell; Edith Aguilar; Ruth Jacobson; Oscar Yanes; Ray Gariano; John Heckenlively; Eyal Banin; G Anthony Ramirez; Mehdi Gasmi; Alan Bird; Gary Siuzdak; Martin Friedlander
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

Review 10.  The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors:  Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal:  J Biomed Biotechnol       Date:  2010-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.